IRIS
ABBADESSA, GIANMARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.649
AS - Asia 1.505
NA - Nord America 992
SA - Sud America 286
AF - Africa 25
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.460
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 961
RU - Federazione Russa 870
SG - Singapore 508
CN - Cina 411
IE - Irlanda 271
HK - Hong Kong 237
BR - Brasile 230
IT - Italia 171
DE - Germania 120
KR - Corea 105
VN - Vietnam 88
GB - Regno Unito 73
IN - India 64
JP - Giappone 39
AR - Argentina 25
FI - Finlandia 23
UA - Ucraina 18
SE - Svezia 17
AT - Austria 13
MX - Messico 13
CA - Canada 12
EC - Ecuador 12
GR - Grecia 12
FR - Francia 10
NL - Olanda 10
CZ - Repubblica Ceca 9
MA - Marocco 9
BE - Belgio 8
ID - Indonesia 8
IQ - Iraq 6
PL - Polonia 6
TR - Turchia 6
CO - Colombia 5
EG - Egitto 5
IL - Israele 5
VE - Venezuela 5
BD - Bangladesh 4
PK - Pakistan 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
ES - Italia 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
ZA - Sudafrica 3
DO - Repubblica Dominicana 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LU - Lussemburgo 2
PA - Panama 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
DK - Danimarca 1
ET - Etiopia 1
EU - Europa 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
LT - Lituania 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
Totale 4.460
Salva come PNG Salva come JPEG
Città #
Moscow 287
Dublin 271
Hong Kong 237
Santa Clara 209
Singapore 184
Hefei 134
Dallas 110
Seoul 101
Chandler 70
Munich 57
Bengaluru 49
Beijing 46
Ashburn 39
Ho Chi Minh City 36
Roxbury 34
Princeton 33
Naples 29
New York 29
Cambridge 26
The Dalles 25
São Paulo 20
Bremen 19
Jacksonville 19
Los Angeles 19
Caserta 15
Hanoi 14
Medford 14
Ann Arbor 13
Boardman 12
Helsinki 11
Milan 11
Falkenstein 9
Brussels 8
Des Moines 8
Rio de Janeiro 8
Stockholm 8
Brasília 6
Chicago 6
Grafing 6
Guangzhou 6
Lappeenranta 6
Mexico City 6
Pasadena 6
San Francisco 6
Tokyo 6
Turku 6
Boston 5
Brno 5
Curitiba 5
Phoenix 5
Porto Alegre 5
Redwood City 5
Rome 5
Vienna 5
Viterbo 5
Wilmington 5
Amsterdam 4
Atlanta 4
Brooklyn 4
Buenos Aires 4
Changsha 4
Frankfurt am Main 4
Nanjing 4
Norwalk 4
Nuremberg 4
Rockville 4
Tashkent 4
Toronto 4
Warsaw 4
Ankara 3
Aversa 3
Bari 3
Columbus 3
Da Nang 3
Darmstadt 3
Guarulhos 3
Guayaquil 3
Houston 3
Hyderabad 3
Hải Dương 3
Jinan 3
Lviv 3
Lấp Vò 3
Marília 3
Meknes 3
Newark 3
Norwich 3
Pune 3
Raleigh 3
São José dos Pinhais 3
Taizhou 3
Tianjin 3
Zurich 3
Aracaju 2
Athens 2
Baghdad 2
Bauru 2
Belém 2
Bexley 2
Bishkek 2
Totale 2.462
Salva come PNG Salva come JPEG
Nome #
Atypical Progressive Multifocal Leukoencephalopathy in a Kidney Transplant Recipient With Improving Symptoms After Immunocompetence Recovery 126
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 107
Telemedicine application to headache: a critical review 105
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis 98
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic 96
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells 95
e-Health and multiple sclerosis: An update 91
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab 87
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 86
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 85
Social Media and Multiple Sclerosis in the Posttruth Age. 85
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study 84
Disability assessment using Google Maps 83
Cd19 cell count at baseline predicts b cell repopulation at 6 and 12 months in multiple sclerosis patients treated with ocrelizumab 82
Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series 81
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 81
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study 80
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic review 78
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis 75
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 75
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 73
Right phrenic nerve palsy following transcatheter radiofrequency current atrial fibrillation ablation: Case report 73
Heidenhain variant of Creutzefeldt-Jackob disease in a patient carrying the V210I mutation with asymmetric MRI abnormalities 73
Impact of early diagnosis on clinical characteristics of an Italian sample of people with multiple sclerosis recruited online. 73
Readability Analysis of Online Headache and Migraine Information 73
Hemostatic factors in the pathogenesis of neuroinflammation in multiple sclerosis 73
Source of medical information and behavioral seeking patterns in patients affected with Friedreich’s ataxia and their caregivers: a survey study 73
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 72
Signs and symptoms of COVID-19 in patients with multiple sclerosis 72
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail 71
Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic 71
MRI and steroid-responsive encephalopathy associated with autoimmune thyroiditis: first report of conus medullaris involvement and literature review of the known neuroimaging profiles 70
Progressive multifocal leukoencephalopathy presenting with bilateral myoclonus: a case report 70
Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis 70
The Use of Social Media and Digital Devices Among Italian Neurologists 67
How to manage with telemedicine people with neuromuscular diseases? 67
Public engagement and neurology: An update 65
Viral pericarditis following ocrelizumab in a multiple sclerosis patient 64
Digital work engagement among Italian neurologists 63
Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis 63
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 61
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 61
Editorial: Bridging the gap between basic neurosciences and clinical neuroimmunology 59
Pain, quality of life, and religiosity in people with multiple sclerosis 59
Hemostasis Components as Therapeutic Targets in Autoimmune Demyelination 59
Paraneoplastic syndrome or immune-related adverse event? A case of rhomboencephalitis in a patient treated with Pembrolizumab 58
Digital therapeutics in neurology 57
Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learning 56
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study 55
Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic Complications 53
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study 51
Glaucoma as a Tauopathy—Is It the Missing Piece in the Glaucoma Puzzle? 49
Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab 48
Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8 + T-Cell Proliferation in Patients With Multiple Sclerosis 47
Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study 47
Behind the scenes: exploring neurological journal editors' work habits, decisions, and potential sources of conflict of interest 47
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics 42
Emotional facial palsy: an unusual and rarely explored neurological sign 42
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab 41
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop) 40
Targeting shared pathways in tauopathies and age-related macular degeneration: implications for novel therapies 40
Modulation of NCX1 expression in monocytes associates with multiple sclerosis progression 39
Reply to Wostyn, P. Targeting the Cerebrospinal Fluid Compartment in Glaucoma: Still the Dark Side of the Moon? Comment on “Passaro et al. Glaucoma as a Tauopathy—Is It the Missing Piece in the Glaucoma Puzzle? J. Clin. Med. 2023, 12, 6900” 39
Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective study 38
First the B cells fall, then the T cells follow: temporal immunological shift with ocrelizumab in multiple sclerosis 37
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors 37
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis 35
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study 34
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression 33
Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis 29
Totale 4.569
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.806
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 0 0 0 0 0 1 11 2 1 4 12 9
2021/2022240 2 15 4 5 60 15 2 3 17 6 23 88
2022/2023416 63 12 9 11 35 18 2 11 222 6 11 16
2023/2024297 16 11 22 13 79 39 13 5 7 4 11 77
2024/20251.150 2 12 10 75 180 114 145 98 198 98 128 90
2025/20262.296 220 382 387 228 486 593 0 0 0 0 0 0
Totale 4.569